ANI Pharmaceuticals' Breakout Year: A Rare Disease Story to Watch ANI Pharmaceuticals, Inc.
's latest earnings call highlights a company in transition, driven by a strategic transformation that's yielding promising results.
Record quarterly revenue and adjusted EBITDA are fueled by a 43% year over year increase in Cortrophin Gel sales.